Product Information
DORZOLAMIDE HCL 2% EYE DROPS is a generic product labeled by Bausch & Lomb Incorporated, priced at $0.8575 per ML under NDC 24208048510. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
20 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208048510
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
DORZOLAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090143On Market Since
6/25/2009
Pharmacological Classes
Price Statistics
The NADAC for DORZOLAMIDE HCL 2% EYE DROPS has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 44.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8575 per ML |
|---|---|
| All-time high | $1.8762 (May 13, 2020) |
| All-time low | $0.8554 (May 20, 2026) |
| 52-week high | $1.3114 |
| 52-week low | $0.8554 |
| Median price | $1.3478 |
| Average price | $1.3489 |
| Largest weekly change | +42.1% (Sep 18, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Dorzolamide HCl market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DORZOLAMIDE HCL 2% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE HCL 2% EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $0.8575 per ML (NDC 24208048510), effective Jun 24, 2026.
How has the price of DORZOLAMIDE HCL 2% EYE DROPS changed over time?
Over the history we have for it, the NADAC for DORZOLAMIDE HCL 2% EYE DROPS has declined 44.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DORZOLAMIDE HCL 2% EYE DROPS?
Since Nov 28, 2013, the NADAC for DORZOLAMIDE HCL 2% EYE DROPS has ranged from a low of $0.8554 (May 20, 2026) to a high of $1.8762 (May 13, 2020), with a median of $1.3478 per ML.
Are there cheaper alternatives to DORZOLAMIDE HCL 2% EYE DROPS?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DORZOLAMIDE HCL 2% EYE DROPS, so no direct lower-cost alternative is listed.
Who manufactures DORZOLAMIDE HCL 2% EYE DROPS?
DORZOLAMIDE HCL 2% EYE DROPS (NDC 24208048510) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.
Related Drugs
Same classification